Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Accounts Payables: 2011-2025

Historic Accounts Payables for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to $8.2 million.

  • Lifecore Biomedical's Accounts Payables fell 49.68% to $8.2 million in Q2 2025 from the same period last year, while for May 2025 it was $8.2 million, marking a year-over-year decrease of 49.68%. This contributed to the annual value of $8.2 million for FY2025, which is 49.68% down from last year.
  • Per Lifecore Biomedical's latest filing, its Accounts Payables stood at $8.2 million for Q2 2025, which was up 11.01% from $7.4 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Accounts Payables high stood at $22.1 million for Q2 2023, and its period low was $7.4 million during Q1 2025.
  • Over the past 3 years, Lifecore Biomedical's median Accounts Payables value was $15.7 million (recorded in 2023), while the average stood at $15.2 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first crashed by 86.04% in 2021, then soared by 70.61% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Accounts Payables (Quarterly) stood at $8.7 million in 2021, then spiked by 53.68% to $13.3 million in 2022, then spiked by 43.02% to $19.0 million in 2023, then fell by 21.32% to $15.0 million in 2024, then plummeted by 49.68% to $8.2 million in 2025.
  • Its Accounts Payables was $8.2 million in Q2 2025, compared to $7.4 million in Q1 2025 and $15.0 million in Q4 2024.